Experience of Health Care Refo rm An overview of SB 459 Laurie Squarts off NV Department of Health and Human Services GOOD SAMARITAN DRUG OVERDOSE ACT Roadmap of Presentation
Origin and Development of Successful Reform Implementation Outcomes State Contacts / Additional Resources 2 3 Origin and Development of
Successful Reform NEVADA DATA 2nd highest for hydrocodone prescriptions (ARCOS) 2nd highest for oxycodone prescriptions (ARCOS) 4th highest for methadone prescriptions (ARCOS) 7th highest for codeine prescriptions (ARCOS) 4th highest drug overdose mortality rate
(Vital Statistics) Over 19% of Nevada High Schools students report that they have taken prescription drugs without a doctors prescription (YRBS) 4 Origin and Development of Successful Reform The goal of the NGA
Prescription Drug Abuse Prevention program is, with improved coordination of statewide resources, to reduce the incidence of inappropriate controlled substance use by Nevadans. 5
Origin and Development of Successful Reform Data Defined Goals Reduce overall prescriptions of hydrocodone and oxycodone (ARCOS data) as well as expansion of MAT providers (DEA) and prescribers (SAPTA) and assurance to access to comprehensive, fully integrated treatment (Medicaid data to access) Reduce the number of overdose deaths (Vital Statistics, Coroner data) Reduce number of high school students that have used a
prescription drug without a prescription (YRBS) 6 Origin and Development of Successful Reform Timeline Date Milestone
July 2014 Announced as Rx Drug Policy Academy Co-Lead September 2014 Ongoing First meeting with National Governors Association (NGA) staff and other states
Stakeholder meetings, core team subcommittee meetings April 2015 Legislative hearings May 5, 2015 Stakeholder meetings, SB459 Signed into Law
June 2015 Reconvening of all states at NGA meeting in Vermont September 2015 Report turned over to Chief of Staff at Governors office 7
Origin and Development of Successful Reform Mandatory Use PDMP PDMP Prescriber Education Requirement
ID Requirement Support for Naloxone Use Doctor Shopping Law Good Samaritan
Law Support for Substance Use Services Pharmacy Lock-Physical Exam In Program Requirement Source linked at end of presentation. Teal slices were TFAH/ASTHO strategies already in place in Nevada and orange slices were added by SB 459.
8 Key components of SB 459 Mandatory Use of PMP
Prescriber Education Requirement Good Samaritan Law Support for Naloxone use Roadmap of Presentation Origin and Development of Successful Reform Implementation Outcomes
State Contacts / Additional Resources 10 Implementation Data collection Community Education Provider Education Law Enforcement Assessment and Treatment
11 Implementation The Nevada DHHS, Substance Abuse and Prevention Agency (SAPTA) and the Multidisciplinary Prevention Advisory Committee (MPAC) and the State Epidemiologic Workgroup (SEW) were selected to manage implementation. MPAC is a partner advisory group with the SEW, both of which advise SAPTA. The SEW collects and analyzes the data and the MPAC 's role is to create recommendations on strategies and funding in relation to the information the SEW
presents. The MPAC also receives Coalition updates. The MPAC meetings provide regular updates on statewide efforts. SAPTA tracks progress and shares information with Governors office. 12 Roadmap of Presentation Origin and Development of Successful Reform Implementation
Outcomes State Contacts / Additional Resources 13 Key components of SB 459
Mandatory Use of PMP Prescriber Education Requirement Good Samaritan Law Support for Naloxone use Outcomes Mandatory access and use by practitioners of Prescription Monitoring Program(PMP)
Practitioners are required to obtain a PMP report before initiating some prescriptions for a controlled substance Outcomes PRESCRIPTION MONITORING PROGRAM Prescription is for a controlled substance (Schedule II,III, or IV) Patient is a new patient for the practitioner; or The prescription is for more than 7 days and is part of a new course of treatment for the patient
Outcomes PRESCRIPTION MONITORING PROGRAM Practitioners are obligated to actually review the PMP reports NRS639.23507(1) does not apply to inpatient chart orders; it does apply to prescriptions written for out-patients by practitioners working in a hospital emergency department Outcomes PRESCRIPTION MONITORING PROGRAM Periodic training for practitioners concerning the misuse and abuse of
controlled substances The language in sections 15.1 through 15.9 is permissive, not mandatory: Outcomes PRESCRIPTION MONITORING PROGRAM The language in sections 15.1 through 15.9 is permissive, not mandatory: Each Board may, by regulation, requirewho is registered to dispense controlled substances pursuant to NRS 453.231 to complete at least 1 hour of training relating specifically to the misuse and abuse
of controlled substances during each period of licensure. Any such holder of a license may use such training to satisfy 1 hour of any continuing education requirement established by the Board. Outcomes ADDITIONAL PROVISIONS IN SB459 Ability for practitioners to Red Flag Doctor Shoppers Section 13 Next Day reporting to the PMP Database Section -13(2) Outcomes
GOOD SAMARITAN OVERDOSE ACT Authority to Prescribe and Dispense to Non-Patients Outcomes GOOD SAMARITAN OVERDOSE ACT Section 7 of SB459 applies to a health care professional otherwise authorized to prescribe an opioid antagonist may directly or by standing order, prescribe and dispense and opioid antagonist to a person other than the patient.
Outcomes GOOD SAMARITAN OVERDOSE ACT Section 7 describes other persons as a family member, friend or other person in a position to assist such a person at risk of experiencing an opioid-related drug overdose. Outcomes GOOD SAMARITAN OVERDOSE ACT Significant departure from traditional pharmacy law. Outside the scope of SB459, prescriptions must be written for the patient in a
prescriber-patient relationship. See NRS 639.235(2) and (4). Prescribers cannot generally write prescriptions for persons who are merely related to or associated with the patient. Outcomes GOOD SAMARITAN OVERDOSE ACT Per the statute, such prescriptions are to be regarded as being issued for a legitimate medical purpose in the usual course of professional practice. Section 7(1) Prescribers who write such a prescription in good faith and with care are
immune from civil or criminal prosecution directly associated with writing the prescription. Section 7(2) Outcomes GOOD SAMARITAN OVERDOSE ACT Section 7(3), not withstanding any other provision of law, any person may possess and administer an opioid antagonist to another person who he or she reasonable believe is experiencing an opioid-related drug overdose.
Outcomes GOOD SAMARITAN OVERDOSE ACT Any person is undefined, but the statute specifically states that law enforcement personnel, EMTs, advanced emergency medical technicians or paramedics are included, as being able to possess and administer an opioid antagonist Outcomes GOOD SAMARITAN OVERDOSE ACT Persons who act in good faith and with reasonable care in
administering an opioid antagonist- although they would have no legal authority to administer other medications-are immune from criminal prosecution, civil liability and sanction from professional licensing boards. Section 7(4) Outcomes GOOD SAMARITAN OVERDOSE ACT Section 7(5) does not create a duty to prescribe or dispense an opioid antagonist. A prescriber who declines to prescribe the medication for any reason is immune from criminal, civil and administrative
proceedings Outcomes GOOD SAMARITAN OVERDOSE ACT Section 8 Authority of unlicensed persons to store, possess and administer opioid antagonists Outcomes GOOD SAMARITAN OVERDOSE ACT Section 8 allows non-registered persons to store and dispense opioid
antagonists pursuant to a standing order from a properly authorized prescriber. The caveat is that those activities [must be] undertaken without charge or compensations. Where the person has a standing order from a prescriber, the person can possess and dispense without charge without a license from the Board of Pharmacy pursuant to NRS Chapter 639. Outcomes GOOD SAMARITAN OVERDOSE ACT Authority of pharmacists to dispense opioid antagonists in accordance with standardized procedures or protocols developed and approved
by the State Board of Pharmacy Recent workshop held on October 15, 2015 Another workshop scheduled for December 2015 Pending regulations will be forwarded to LCB before adoption Outcomes GOOD SAMARITAN OVERDOSE ACT Section 12 addresses protections for persons who seek medical assistance for another person who is experiencing a drug or alcohol overdose
Outcomes GOOD SAMARITAN OVERDOSE ACT Section 12(1) says that if a person seeks aid in good faith on behalf of himself/herself, or for another, that person may not be arrested, charged, prosecuted or convicted, or have his or her property subjected to forfeiture or other penalty. Outcomes GOOD SAMARITAN OVERDOSE ACT
Even in cases where immunities in subsection 12(1) do not apply, the Court, before sentencing, shall consider in mitigation any evidence or information that the defendant, in good faith, sough medical assistance for a person in connection with the events that led to the violation. Section 12(2). Outcomes ISSUES STILL AT HAND Section 10: DHHS MAY MONITOR/WATCH CHANGE TRENDS IN RISK FACTORS AND PUBLISH ANNUAL
REPORT Outcomes IMPORTANT TO ASSURE THAT PAIN PATIENTS RECEIVE APPROPRIATE TREATMENT WITHOUT BARRIERS Roadmap of Presentation Origin and Development of Successful Reform
Implementation Outcomes State Contacts / More Information 38 State Contacts / More Information State Contacts Larry Pinson, Pharm.D., Nevada State Board of Pharmacy; [email protected]; 775-850-1440 Tracey Green MD, Chief Medical Officer: [email protected], 775-684-3215
Dena Schmidt, Deputy Director, DHHS: [email protected], 775-684-4015 Laurie Squartsoff, R.Ph, DPBH: [email protected], 725-500-2913 More Information Nevada Legislature: http://www.leg.state.nv.us/ SB459: https://www.leg.state.nv.us/App/NELIS/REL/78th2015/Bill/2161/Text SAPTA: http://mh.nv.gov/Meetings/SAPTA_Program_Page/ Trust for Americas Health Report: http://healthyamericans.org/reports/drugabuse2013/ Data Resources: http://dpbh.nv.gov/Programs/OPHIE/Public_Health_Informatics_and_Epidemiology_-_Home/ YRBS data for NV: https://dhs.unr.edu/chs/research/yrbs
39 Experience of Health Care Reform An overview of SB 459 40 Experience of Health Care Reform An overview of SB 459
Collision Theory * * * * * * * * * * Reactions are fastest with… Large Ea, Large T Low Ea, Large T Large Ea, Low T Low Ea, Low T Reaction Coordinate Diagrams Multistep Reactions Arrhenius Equation: Temperature...
Student Performance. Next Steps. Define performance targets. Work-based learning. sustained interactions with industry or community professionals in real workplace settings, to the extent practicable, or simulated environments at an educational institution that foster in-depth, firsthand engagement with the tasks required...
Biochemical Network Notation x0 = scaled population x1 = mRNA transcribed from OL x2 = mRNA transcribed from OR x3 = protein LuxR x4 = protein LuxI x5 = protein LuxA/B x6 = protein LuxC/D/E x7 = autoinducer Ai x8...
The Multi-store model of memory: re-visited Where did we learn about this model What do we know about it already? Any supporting research evidence? Progress Wall Where does it fit in? You need to know about 3 models of memory:...
My hope is for this presentation to be used as a best practices document help your customers come up with an educated decision of what devices to deploy and why. ... Network Scanners are the new kid on the block...
Can you think of a way to test the idea that regeneration is adaptive? Hermit Crabs regenerate their anterior and posterior limbs. However, the frequency of regeneration is much higher for anterior legs (83% vs 21%). From Morgan 1898 and...
Ready to download the document? Go ahead and hit continue!